Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 36 of 99

  1. Dupilumab (SAR231893)

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  2. Dupilumab (SAR231893)

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  3. E0302 SR1

    Eisai Co.,

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  4. E303-1001

    Samsung Bioepis NL B.V.

    advanced refractory solid tumors

    phase 1 other active

    1 trial

  5. E6007

    Eisai Co.,

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. E7080

    Eisai Co.,

    Cancer: Solid Tumors

    phase 1 small molecule completed

    1 trial

  7. E7766

    Eisai Co.,

    Lymphoma

    phase 1 small molecule terminated

    1 trial

  8. EBC-129

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumours

    phase 1 small molecule active

    1 trial

  9. EBV immunological agent

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Malignant Tumor

    phase 1 mab active

    1 trial

  10. ECHO (Empowering Our Community & Health Outcomes)

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 1 other terminated

    1 trial

  11. ECIG liquid vehicles

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Exposure

    phase 1 other completed

    1 trial

  12. EDG-15400

    Edgewise Therapeutics

    Healthy Adults

    phase 1 small molecule active

    1 trial

  13. EDG-5506

    Edgewise Therapeutics

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  14. EDG-5506

    Edgewise Therapeutics

    Muscular Dystrophies

    phase 1 small molecule completed

    1 trial

  15. EDG-5506 Tablet

    Edgewise Therapeutics

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  16. EDG-7500

    Edgewise Therapeutics

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  17. EDG-7500

    Edgewise Therapeutics

    Healthy Adult Participants

    phase 1 small molecule active

    1 trial

  18. EDG-7500

    Edgewise Therapeutics

    Hepatic Impairment (HI)

    phase 1 small molecule active

    1 trial

  19. EDG-7500

    Edgewise Therapeutics

    Renal Impairments

    phase 1 small molecule completed

    1 trial

  20. EDP 305

    ENANTA PHARMACEUTICALS INC

    NASH

    phase 1 small molecule completed

    1 trial

  21. EDP 305

    ENANTA PHARMACEUTICALS INC

    Presumptive NAFLD

    phase 1 small molecule completed

    1 trial

  22. EDP-235

    ENANTA PHARMACEUTICALS INC

    SARS CoV 2 Infection

    phase 1 small molecule completed

    1 trial

  23. EDP-297

    ENANTA PHARMACEUTICALS INC

    NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis

    phase 1 small molecule completed

    1 trial

  24. EDP-305

    ENANTA PHARMACEUTICALS INC

    NASH - Nonalcoholic Steatohepatitis

    phase 1 small molecule completed

    2 trials

  25. EDP-322

    ENANTA PHARMACEUTICALS INC

    Skin and Soft Tissue Infections

    phase 1 small molecule completed

    1 trial

  26. EDP-322

    ENANTA PHARMACEUTICALS INC

    MRSA, SSTI

    phase 1 small molecule completed

    1 trial

  27. EDP-323

    ENANTA PHARMACEUTICALS INC

    RSV Infection

    phase 1 small molecule completed

    3 trials

  28. EDP-494

    ENANTA PHARMACEUTICALS INC

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  29. EDP-514

    ENANTA PHARMACEUTICALS INC

    Hepatitis B

    phase 1 small molecule completed

    1 trial

  30. EDP-514

    ENANTA PHARMACEUTICALS INC

    Chronic HBV Infection

    phase 1 small molecule completed

    2 trials

  31. EDP-721

    ENANTA PHARMACEUTICALS INC

    Chronic Hepatitis B Virus Infection

    phase 1 small molecule terminated

    1 trial

  32. EDP-788

    ENANTA PHARMACEUTICALS INC

    Safety in Normal Volunteers

    phase 1 small molecule completed

    1 trial

  33. EDP-788

    ENANTA PHARMACEUTICALS INC

    Healthy

    phase 1 small molecule terminated

    1 trial

  34. EDP-978

    ENANTA PHARMACEUTICALS INC

    Chronic Inducible Urticaria

    phase 1 small molecule active

    1 trial

  35. EDP239

    ENANTA PHARMACEUTICALS INC

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  36. ELI-002 2P

    Elicio Therapeutics

    Minimal Residual Disease

    phase 1 small molecule completed

    1 trial

  37. ELVN-001

    Enliven Therapeutics

    Chronic Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  38. ELVN-001

    Enliven Therapeutics

    CML (Chronic Myelogenous Leukemia)

    phase 1 small molecule active

    1 trial

  39. ELVN-002

    Enliven Therapeutics

    HER2-positive Breast Cancer

    phase 1 small molecule active

    1 trial

  40. ELVN-002

    Enliven Therapeutics

    HER2 Mutant Non-small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  41. ELX-02

    Eloxx Pharmaceuticals

    Impaired Renal Function

    phase 1 small molecule completed

    1 trial

  42. ELX-02

    Eloxx Pharmaceuticals

    Genetic Diseases

    phase 1 small molecule terminated

    1 trial

  43. EMBER: A Study of LY3484356 in Patients with Breast or Other Non-Breast Cancers

    Eli Lilly Co.

    Breast Cancer, Endometrial cancer

    phase 1 other active

    1 trial

  44. EMPAG-05-24

    Lacuna Pharma Pty Ltd

    Diabetes

    phase 1 other active

    1 trial

  45. ENA-001

    BRIGHT MINDS BIOSCIENCES INC.

    Respiratory Depression

    phase 1 small molecule active

    1 trial

  46. ENMD-2076

    CASI Pharmaceuticals

    Multiple Myeloma

    phase 1 small molecule completed

    1 trial

  47. ENMD-2076

    CASI Pharmaceuticals

    Relapsed or Refractory Hematological Malignancies

    phase 1 small molecule completed

    1 trial

  48. ENMD-2076

    CASI Pharmaceuticals

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.